Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
The design and synthesis of the high efficacy, non-peptide CCK1 receptor agonist PD170292N Bernad, B G Burgaud, D C Horwell, et al.British Journal of Pharmacology|October 1, 1995
Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosaA Heinemann, M Jocic, U Holzer-Petsche, et al.Pharmaceutical Research|August 4, 1998
Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compoundsO H Chan, H L Schmid, L A Stilgenbauer, et al.Journal of Medicinal Chemistry|January 1, 1991
Highly selective kappa opioid analgesics. 4. Synthesis of some conformationally restricted naphthalene derivatives with high receptor affinity and selectivityP R Halfpenny, D C Horwell, J Hughes, et al.International Journal of Peptide and Protein Research|December 1, 1996
Alanine scan and N-methyl amide derivatives of Ac-bombesin[7-14]. Development of a proposed binding conformation at the neuromedin B (NMB) and gastrin releasing peptide (GRP) receptorsD C Horwell, W Howson, D Naylor, et al.Journal of Medicinal Chemistry|July 1, 1989
Highly selective kappa-opioid analgesics. 2. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide derivativesP R Halfpenny, R G Hill, D C Horwell, et al.Journal of Medicinal Chemistry|January 1, 1991
Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic propertiesD C Horwell, J Hughes, J C Hunter, et al.British Journal of Pharmacology|September 1, 1990
CI-977, a novel and selective agonist for the kappa-opioid receptorJ C Hunter, G E Leighton, K G Meecham, et al.Regulatory Peptides|August 27, 1996
Characterization of novel peptoid agonists for the CCK-A receptorJ Hughes, G J Dockray, D Hill, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activityJ Hughes, P Boden, B Costall, et al.Pageof 5